357 related articles for article (PubMed ID: 17948171)
1. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention.
Graf TN; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
Planta Med; 2007 Nov; 73(14):1495-501. PubMed ID: 17948171
[TBL] [Abstract][Full Text] [Related]
2. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
3. Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships.
Sy-Cordero A; Graf TN; Nakanishi Y; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
Planta Med; 2010 Apr; 76(6):644-7. PubMed ID: 19941262
[TBL] [Abstract][Full Text] [Related]
4. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
5. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
[TBL] [Abstract][Full Text] [Related]
6. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
[TBL] [Abstract][Full Text] [Related]
7. Flavonolignans from Aspergillus iizukae, a fungal endophyte of milk thistle (Silybum marianum).
El-Elimat T; Raja HA; Graf TN; Faeth SH; Cech NB; Oberlies NH
J Nat Prod; 2014 Feb; 77(2):193-9. PubMed ID: 24456525
[TBL] [Abstract][Full Text] [Related]
8. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations.
AbouZid SF; Ahmed HS; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Brent Friesen J; Pauli GF
Fitoterapia; 2017 Jun; 119():175-184. PubMed ID: 28392269
[TBL] [Abstract][Full Text] [Related]
9. Separation and characterization of active flavonolignans of Silybum marianum by liquid chromatography connected with hybrid ion-trap and time-of-flight mass spectrometry (LC-MS/IT-TOF).
Shibano M; Lin AS; Itokawa H; Lee KH
J Nat Prod; 2007 Sep; 70(9):1424-8. PubMed ID: 17764149
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of silymarin by Ag+ elicitor in cell suspension cultures of Silybum marianum.
Ashtiani SR; Hasanloo T; Bihamta MR
Pharm Biol; 2010 Jun; 48(6):708-15. PubMed ID: 20645746
[TBL] [Abstract][Full Text] [Related]
11. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle).
Lee DY; Liu Y
J Nat Prod; 2003 Sep; 66(9):1171-4. PubMed ID: 14510591
[TBL] [Abstract][Full Text] [Related]
12. Isolation and purification of diastereoisomeric flavonolignans from silymarin by binary-column recycling preparative high-performance liquid chromatography.
Zhao W; Yang G; Zhong F; Yang N; Zhao X; Qi Y; Fan G
J Sep Sci; 2014 Sep; 37(17):2300-6. PubMed ID: 24923482
[TBL] [Abstract][Full Text] [Related]
13. Silyamandin, a new flavonolignan isolated from milk thistle tinctures.
MacKinnon SL; Hodder M; Craft C; Simmons-Boyce J
Planta Med; 2007 Sep; 73(11):1214-6. PubMed ID: 17823870
[TBL] [Abstract][Full Text] [Related]
14. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the analysis of flavonolignans of Silybum marianum.
Csupor D; Csorba A; Hohmann J
J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic study of the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle.
Althagafy HS; Meza-Aviña ME; Oberlies NH; Croatt MP
J Org Chem; 2013 Aug; 78(15):7594-600. PubMed ID: 23876147
[TBL] [Abstract][Full Text] [Related]
18. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies.
Kroll DJ; Shaw HS; Oberlies NH
Integr Cancer Ther; 2007 Jun; 6(2):110-9. PubMed ID: 17548790
[TBL] [Abstract][Full Text] [Related]
19. A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties.
Romanucci V; Di Fabio G; Zarrelli A
Molecules; 2018 Dec; 24(1):. PubMed ID: 30597952
[TBL] [Abstract][Full Text] [Related]
20. Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.
Deep G; Gangar SC; Rajamanickam S; Raina K; Gu M; Agarwal C; Oberlies NH; Agarwal R
PLoS One; 2012; 7(4):e34630. PubMed ID: 22514647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
